Mechanism-based corrector combination restores ΔF508-CFTR folding and function

The most common cystic fibrosis (CF) mutation, ΔF508 in the nucleotide binding domain-1 (NBD1), impairs CFTR coupled-domain folding, plasma membrane (PM) expression, function and stability. VX-809, a promising investigational corrector of ΔF508-CFTR misprocessing, has limited clinical benefit and in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Okiyoneda, Tsukasa, Veit, Guido, Dekkers, Johanna F., Bagdany, Miklos, Soya, Naoto, Xu, Haijin, Roldan, Ariel, Verkman, Alan S., Kurth, Mark, Simon, Agnes, Hegedus, Tamas, Beekman, Jeffrey M., Lukacs, Gergely L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840170/
https://ncbi.nlm.nih.gov/pubmed/23666117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.1253
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller